Fed Regist. 2010 Aug 6;75(151):47460-1.
The Department is publishing this final rule to implement section 703 of the National Defense Authorization Act (NDAA) for Fiscal Year 2007 (FY07), Public Law 109-364. Specifically, that legislation authorizes breast cancer screening and cervical cancer screening for female beneficiaries of the Military Health System, instead of constraining such testing to mammograms and Papanicolaou smears. The rule allows coverage for "breast cancer screening" and "cervical cancer screening" for female beneficiaries of the Military Health System, instead of constraining such testing to mammograms and Papanicolaou tests. This rule ensures new breast and cervical cancer screening procedures can be added to the TRICARE benefit as such procedures are proven to be a safe, effective, and nationally accepted medical practice. This amends the cancer specific recommendations for breast and cervical cancer screenings to be brought in line with the processes for updating other cancer screening recommendations. In response to public comment on the proposed rule, this final rule includes a clarification that the benefit encompasses screening based on Health and Human Services guidelines.
该部门正在发布此最终规则,以实施2007财年《国防授权法案》(NDAA)第703条,即公法109 - 364。具体而言,该立法授权为军事医疗系统的女性受益人进行乳腺癌筛查和宫颈癌筛查,而不是将此类检测限制在乳房X光检查和巴氏涂片检查。该规则允许为军事医疗系统的女性受益人提供“乳腺癌筛查”和“宫颈癌筛查”,而不是将此类检测限制在乳房X光检查和巴氏试验。此规则确保新的乳腺癌和宫颈癌筛查程序可以添加到特里卡尔医疗保健福利中,因为此类程序已被证明是安全、有效的且被全国认可的医疗实践。这修订了乳腺癌和宫颈癌筛查的特定癌症建议,使其与更新其他癌症筛查建议的流程保持一致。针对对拟议规则的公众意见,此最终规则包括一项澄清,即该福利涵盖基于卫生与公众服务部指南的筛查。